
Tandem Diabetes Care TNDM
$ 15.96
-9.37%
Quarterly report 2026-Q1
added 05-07-2026
Tandem Diabetes Care DSO Ratio 2011-2026 | TNDM
Annual DSO Ratio Tandem Diabetes Care
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 176 | 142 | 53.8 | 51.4 | 50.1 | 47.1 | 46.9 | 69.9 | 70.5 | 48.4 | 70.4 | 56.2 | 66.7 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 176 | 46.9 | 73 |
Quarterly DSO Ratio Tandem Diabetes Care
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.2 | 46.6 | 48.3 | 46.9 | - | 38.4 | 39.3 | 47.2 | - | 48.9 | 44.3 | 55.5 | - | 25.2 | 21.4 | 53.1 | 43.1 | 42.6 | 40.8 | 50.4 | 44.6 | 60.7 | 68.7 | 60 | 39.2 | 44.9 | 39 | 47.2 | 42.1 | 69.4 | 94.1 | 93.7 | 47.1 | 70.3 | 89 | 76.8 | 35.3 | 82.9 | 44.4 | 57.4 | 44 | 81.6 | 81.7 | 80.5 | 39 | 51.7 | 68.1 | 73.3 | 47.2 | 62.2 | 87.5 | 44.3 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 94.1 | 21.4 | 55.3 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
104 | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
50.8 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
55.6 | $ 13.65 | 0.44 % | $ 387 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
43.1 | $ 8.14 | -1.51 % | $ 1.22 B | ||
|
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
IRIDEX Corporation
IRIX
|
26.4 | $ 1.13 | 0.9 % | $ 19.1 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
2.12 | $ 1.42 | -4.05 % | $ 31.3 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.41 | -3.08 % | $ 25.5 M | ||
|
LivaNova PLC
LIVN
|
53.8 | $ 78.25 | 1.4 % | $ 4.27 B | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 18.39 | -0.54 % | $ 431 M | ||
|
Pulmonx Corporation
LUNG
|
50.8 | $ 1.46 | -4.9 % | $ 59.4 M | ||
|
Delcath Systems
DCTH
|
48.5 | $ 11.27 | -3.59 % | $ 404 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
LENSAR
LNSR
|
38.9 | $ 5.67 | -0.35 % | $ 67.8 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Orthofix Medical
OFIX
|
60 | $ 9.73 | -1.42 % | $ 385 M | ||
|
Electromed
ELMD
|
137 | $ 36.98 | 1.9 % | $ 313 M | ||
|
MiMedx Group
MDXG
|
57.3 | $ 3.64 | -2.02 % | $ 538 M | ||
|
Butterfly Network
BFLY
|
88.9 | $ 5.42 | 5.56 % | $ 1.34 B | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
35.3 | $ 1.54 | 16.29 % | $ 64.5 M | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
76.8 | $ 81.0 | -1.85 % | $ 11 B | ||
|
Insulet Corporation
PODD
|
15.2 | $ 150.43 | -5.75 % | $ 10.6 B | ||
|
Profound Medical Corp.
PROF
|
161 | $ 6.72 | -1.47 % | $ 203 M | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 36.17 | -1.87 % | $ 1.12 B | ||
|
Inspire Medical Systems
INSP
|
42.6 | $ 42.31 | 0.31 % | $ 1.24 B | ||
|
Integer Holdings Corporation
ITGR
|
58.2 | $ 92.16 | -1.93 % | $ 3.2 B | ||
|
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
38.2 | $ 85.44 | -2.38 % | $ 50 B | ||
|
Sintx Technologies
SINT
|
67 | $ 2.1 | -0.71 % | $ 5.82 M |